Verified peer comparison
Liquidia vs BioCryst Pharmaceuticals Financial Comparison
Direct answer
Liquidia and BioCryst Pharmaceuticals are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Liquidia email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Liquidia Revenue
- 158,320,000 USD
- BioCryst Pharmaceuticals Revenue
- 874,837,000 USD
- Liquidia Operating income
- -51,376,000 USD
- BioCryst Pharmaceuticals Operating income
- 340,989,000 USD